Comparative analysis of corticosteroid injection alone versus combined corticosteroid and radiofrequency ablation for plantar fasciitis: short- and medium-term outcomes
Turkish Journal of Medical Sciences · 13.08.2026 · 56 (4) · 1065-1073
DOI: 10.55730/1300-0144.6350 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Turkish Journal of Medical Sciences, online erschienen am 13.08.2026. Verfasst von Nevcihan Şahutoğlu Bal und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pain Medicine, Ankara Bilkent City Hospital, Ankara, Turkiye. Hauptthemen laut MEDLINE: Fasciitis, Plantar, Radiofrequency Ablation, Adrenal Cortex Hormones. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/aim: Plantar fasciitis (PF) is a common cause of heel pain and may lead to functional impairment and reduced quality of life. This study aimed to compare the short- and medium-term clinical outcomes of corticosteroid injection (CSI) alone versus combined radiofrequency ablation (RFA) and CSI in patients with PF refractory to conservative treatment. Materials and methods: This single-center retrospective comparative study included patients diagnosed with PF between 1 January 2021 and 1 January 2025. Patients who underwent either CSI alone or combined RFA and CSI after failure of conservative management were included. Pain intensity was assessed using a visual analog scale (VAS) at baseline, 1 week, 3 months, and 6 months. Global perceived effect (GPE) scores were evaluated at 1 week, 3 months, and 6 months.
Results
Both treatment groups demonstrated significant improvements in VAS scores at 1 week, 3 months, and 6 months compared to baseline (p < 0.001 for all). Baseline and 1-week VAS scores were comparable between the groups (p > 0.05). However, median VAS scores at 3 and 6 months were significantly lower in the group receiving combined RFA and CSI compared to CSI alone (p < 0.001). GPE scores at 1 week did not differ significantly (p = 0.100), but at 3 and 6 months, they were significantly higher in the combined group (p < 0.001). In adjusted longitudinal analysis, the group receiving combined RFA and CSI had lower overall VAS scores over time, with significant group × time interactions at 3 and 6 months.
Conclusion
Both CSI alone and combined RFA and CSI provide significant short- and medium-term pain relief. However, the addition of RFA to CSI is associated with superior midterm pain control and greater patient-reported clinical improvement.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pain Medicine, Ankara Bilkent City Hospital, Ankara, Turkiye.
ORCID-Profile: Nevcihan Şahutoğlu Bal, Emel Başar, Hatice Babaoğlan, Mustafa Cem Yilmaz, Ülkü Sabuncu, Şükriye Dadali, Erkan Yavuz Akçaboy
Zitieren
APA
Şahutoğlu Bal, N., Başar, E., Babaoğlan, H., Yilmaz, M. C., Sabuncu, Ü., Dadali, Ş., & Akçaboy, E. Y. (2026). Comparative analysis of corticosteroid injection alone versus combined corticosteroid and radiofrequency ablation for plantar fasciitis: short- and medium-term outcomes . Turkish Journal of Medical Sciences, 56(4), 1065-1073. https://doi.org/10.55730/1300-0144.6350
Vancouver
Şahutoğlu Bal N, Başar E, Babaoğlan H, Yilmaz MC, Sabuncu Ü, Dadali Ş, et al. Comparative analysis of corticosteroid injection alone versus combined corticosteroid and radiofrequency ablation for plantar fasciitis: short- and medium-term outcomes . Turkish Journal of Medical Sciences. 2026;56(4):1065-1073. doi:10.55730/1300-0144.6350
BibTeX
@article{ahutoluBal2026,
author = {Şahutoğlu Bal, Nevcihan and Başar, Emel and Babaoğlan, Hatice and Yilmaz, Mustafa Cem and Sabuncu, Ülkü and Dadali, Şükriye and Akçaboy, Erkan Yavuz},
title = {Comparative analysis of corticosteroid injection alone versus combined corticosteroid and radiofrequency ablation for plantar fasciitis: short- and medium-term outcomes },
journal = {Turkish Journal of Medical Sciences},
year = {2026},
volume = {56},
number = {4},
pages = {1065--1073},
doi = {10.55730/1300-0144.6350}
}
EUVIMED